278 related articles for article (PubMed ID: 18396788)
1. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
[TBL] [Abstract][Full Text] [Related]
2. [Constitutive expression of the potential stem cell marker CD44 in permanent HNSCC cell lines].
Pries R; Wittkopf N; Hasselbacher K; Wollenberg B
HNO; 2008 Apr; 56(4):461-6. PubMed ID: 18368378
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
[TBL] [Abstract][Full Text] [Related]
4. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.
Wang SJ; Wreesmann VB; Bourguignon LY
Head Neck; 2007 Jun; 29(6):550-8. PubMed ID: 17252589
[TBL] [Abstract][Full Text] [Related]
5. Stem cell profiling in head and neck cancer reveals an Oct-4 expressing subpopulation with properties of chemoresistance.
Reers S; Pfannerstill AC; Maushagen R; Pries R; Wollenberg B
Oral Oncol; 2014 Mar; 50(3):155-62. PubMed ID: 24387977
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cells in head and neck squamous cell cancer.
Prince ME; Ailles LE
J Clin Oncol; 2008 Jun; 26(17):2871-5. PubMed ID: 18539966
[TBL] [Abstract][Full Text] [Related]
7. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
[TBL] [Abstract][Full Text] [Related]
8. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
Scher RL
Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.
Van Hal NL; Van Dongen GA; Ten Brink CB; Heider KH; Rech-Weichselbraun I; Snow GB; Brakenhoff RH
Clin Cancer Res; 1999 Nov; 5(11):3534-41. PubMed ID: 10589769
[TBL] [Abstract][Full Text] [Related]
10. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
[TBL] [Abstract][Full Text] [Related]
11. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
[TBL] [Abstract][Full Text] [Related]
12. The stem cell hypothesis in head and neck cancer.
Graziano A; d'Aquino R; Tirino V; Desiderio V; Rossi A; Pirozzi G
J Cell Biochem; 2008 Feb; 103(2):408-12. PubMed ID: 17546610
[TBL] [Abstract][Full Text] [Related]
13. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness.
Joshua B; Kaplan MJ; Doweck I; Pai R; Weissman IL; Prince ME; Ailles LE
Head Neck; 2012 Jan; 34(1):42-9. PubMed ID: 21322081
[TBL] [Abstract][Full Text] [Related]
14. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
15. SDF-1-CXCR4 axis: cell trafficking in the cancer stem cell niche of head and neck squamous cell carcinoma.
Faber A; Goessler UR; Hoermann K; Schultz JD; Umbreit C; Stern-Straeter J
Oncol Rep; 2013 Jun; 29(6):2325-31. PubMed ID: 23563306
[TBL] [Abstract][Full Text] [Related]
16. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
Sterz CM; Kulle C; Dakic B; Makarova G; Böttcher MC; Bette M; Werner JA; Mandic R
Oral Oncol; 2010 Feb; 46(2):116-22. PubMed ID: 20036607
[TBL] [Abstract][Full Text] [Related]
17. Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood.
Nitsch SM; Pries R; Wollenberg B
In Vivo; 2007; 21(3):493-8. PubMed ID: 17591359
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor interference in myeloid dendritic cells through head and neck cancer.
Frenzel H; Hoffmann B; Brocks C; Schlenke P; Pries R; Wollenberg B
Anticancer Res; 2006; 26(6B):4409-13. PubMed ID: 17201162
[TBL] [Abstract][Full Text] [Related]
19. The effects of CD44 down-regulation on stem cell properties of head and neck cancer cell lines.
Kidwai F; Costea DE; Hutchison I; Mackenzie I
J Oral Pathol Med; 2013 Oct; 42(9):682-90. PubMed ID: 23627635
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.
Maula SM; Luukkaa M; Grénman R; Jackson D; Jalkanen S; Ristamäki R
Cancer Res; 2003 Apr; 63(8):1920-6. PubMed ID: 12702584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]